Self-retained cryopreserved amniotic membrane in treating acute ocular graft-versus-host-disease (oGVHD)
Open Access
- 1 September 2020
- journal article
- Published by Elsevier in American Journal of Ophthalmology Case Reports
- Vol. 19, 100761
Abstract
No abstract availableKeywords
Funding Information
- American Society of Cataract and Refractive Surgery
This publication has 9 references indexed in Scilit:
- Amniotic membrane transplantation—a new approach to crossing the HLA barriers in the treatment of refractory ocular graft-versus-host diseaseBone Marrow Transplantation, 2018
- Adjunctive role of self-retained cryopreserved amniotic membrane in treating immune-related dry eye diseaseInternational Ophthalmology, 2017
- Heavy Chain-Hyaluronan/Pentraxin 3 from Amniotic Membrane Suppresses Inflammation and Scarring in Murine Lacrimal Gland and Conjunctiva of Chronic Graft-versus-Host DiseaseScientific Reports, 2017
- Current Approaches to Treatment of Ocular Graft-Versus-Host DiseaseInternational Ophthalmology Clinics, 2017
- Accelerated Restoration of Ocular Surface Health in Dry Eye Disease by Self-Retained Cryopreserved Amniotic MembraneThe Ocular Surface, 2016
- International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: Proposed Diagnostic Criteria for Chronic GVHD (Part I)Scientific Reports, 2013
- Update on amniotic membrane transplantationExpert Review of Ophthalmology, 2010
- Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host diseaseBone Marrow Transplantation, 2003
- Multilayer Amniotic Membrane Transplantation in Severe Ocular Graft versus Host DiseaseEuropean Journal of Ophthalmology, 2001